NEW YORK (GenomeWeb) – OpGen announced today that it has closed its previously announced public offering, raising $12 million in gross proceeds.

The offering comprised about 2.8 million units at $3.25 per unit, and 851,155 pre-funded units at $3.24 per-refunded unit.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.